HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young-Hoon Han Selected Research

Vimentin

12/2016IL-4, a direct target of miR-340/429, is involved in radiation-induced aggressive tumor behavior in human carcinoma cells.
1/2013Bcl-w Enhances Mesenchymal Changes and Invasiveness of Glioblastoma Cells by Inducing Nuclear Accumulation of β-Catenin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young-Hoon Han Research Topics

Disease

21Neoplasms (Cancer)
07/2021 - 02/2004
5Glioblastoma (Glioblastoma Multiforme)
07/2015 - 01/2013
4Colorectal Neoplasms (Colorectal Cancer)
07/2021 - 10/2016
4Glioma (Gliomas)
04/2015 - 07/2013
2Neoplasm Metastasis (Metastasis)
12/2016 - 10/2016
2Carcinogenesis
12/2016 - 10/2016
2Breast Neoplasms (Breast Cancer)
10/2016 - 07/2016
2Leukemia
09/2008 - 05/2007
1Comminuted Fractures
11/2021
1Patellofemoral Pain Syndrome
11/2021
1Patella Fracture
11/2021
1Melanoma (Melanoma, Malignant)
01/2018
1Carcinoma (Carcinomatosis)
12/2016
1Ductal Carcinoma
10/2016
1Laryngeal Neoplasms (Laryngeal Cancer)
02/2015
1Colonic Neoplasms (Colon Cancer)
06/2014
1Stomach Neoplasms (Stomach Cancer)
01/2014
1Adenocarcinoma
01/2013
1Brain Neoplasms (Brain Tumor)
01/2013
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2007
1Prostatic Neoplasms (Prostate Cancer)
05/2007
1Lung Neoplasms (Lung Cancer)
12/2003

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
10/2016 - 02/2004
7MicroRNAs (MicroRNA)IBA
08/2019 - 07/2013
4CateninsIBA
12/2016 - 01/2013
2VimentinIBA
12/2016 - 01/2013
2CytokinesIBA
12/2016 - 02/2016
2Messenger RNA (mRNA)IBA
07/2015 - 01/2014
2Small Interfering RNA (siRNA)IBA
02/2015 - 12/2003
2shikoninIBA
06/2014 - 11/2008
2Transcription Factors (Transcription Factor)IBA
01/2013 - 11/2010
24- (3- (1- adamantyl)- 4- hydroxyphenyl)- 3- chlorocinnamic acidIBA
09/2008 - 05/2007
2Orphan Nuclear ReceptorsIBA
09/2008 - 02/2004
2RetinoidsIBA
09/2008 - 05/2007
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
05/2007 - 02/2004
1Histone Deacetylases (Histone Deacetylase)IBA
07/2021
1Fatty Acids (Saturated Fatty Acids)IBA
12/2020
1Butyrates (Butyrate)IBA
12/2020
1Trypan BlueFDA Link
08/2019
1VemurafenibIBA
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2016
1Matrix Metalloproteinases (MMPs)IBA
12/2016
1Interleukin-4 (Interleukin 4)IBA
12/2016
1Cadherins (E-Cadherin)IBA
10/2016
1Apolipoprotein E3IBA
02/2016
1mouse MIRN29 microRNAIBA
07/2015
1Pharmaceutical PreparationsIBA
07/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2014
1rho GTPase-activating proteinIBA
03/2014
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2014
1Oncogene Proteins (Oncogene Protein)IBA
11/2010
1Telomerase (Telomerase Reverse Transcriptase)IBA
11/2010
1Retinoid X Receptor alphaIBA
06/2010
1Tyrosine (L-Tyrosine)FDA Link
09/2008
1Hydroxyl RadicalIBA
09/2008
1AcidsIBA
09/2008
1phosphonic acidIBA
05/2007
1Boronic AcidsIBA
05/2007
11H-tetrazole (tetrazole)IBA
05/2007
1Protein Tyrosine PhosphatasesIBA
05/2007
1thiazolidine-2,4-dioneIBA
05/2007
1Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA
05/2007
1Hydroxamic Acids (Hydroxamic Acid)IBA
05/2007
1Antineoplastic Agents (Antineoplastics)IBA
02/2004
1Bromodeoxyuridine (BrdU)IBA
12/2003
1Epidermal Growth Factor (EGF)IBA
12/2003

Therapy/Procedure

6Radiotherapy
07/2021 - 06/2014
3Therapeutics
07/2014 - 07/2013
1Suture Anchors
11/2021
1Suture Techniques
11/2021
1Sutures (Suture)
11/2021